bezafibrate has been researched along with Cerebral Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D | 1 |
| Adler, Y; Behar, S; Benderly, M; Fisman, EZ; Goldbourt, U; Haim, M; Matas, Z; Tanne, D; Tenenbaum, A; Zimmlichman, R | 1 |
| Goldbourt, U; Koren-Morag, N; Tanne, D | 1 |
| Goldbourt, U; Graff, E; Koren-Morag, N; Tanne, D | 1 |
| Aspey, BS; Ehteshami, S; Harrison, MJ; Hurst, CM; Pereira, S | 1 |
2 trial(s) available for bezafibrate and Cerebral Ischemia
| Article | Year |
|---|---|
Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke.
Topics: Aged; Bezafibrate; Brain Ischemia; Confidence Intervals; Coronary Disease; Female; Follow-Up Studies; Heart Rate; Humans; Hypolipidemic Agents; Incidence; Male; Middle Aged; Prognosis; Proportional Hazards Models; Retrospective Studies; Societies, Medical; Time Factors | 2008 |
Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry.
Topics: Adult; Aged; Bezafibrate; Brain Ischemia; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Disease; Follow-Up Studies; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Lovastatin; Middle Aged; Multivariate Analysis; Odds Ratio; Registries; Risk Factors; Survival Analysis; Time Factors | 2002 |
3 other study(ies) available for bezafibrate and Cerebral Ischemia
| Article | Year |
|---|---|
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke | 2002 |
C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.
Topics: Aged; Angina Pectoris; Bezafibrate; Brain Ischemia; C-Reactive Protein; Cerebral Infarction; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypolipidemic Agents; Incidence; Israel; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment | 2006 |
Effect of bezafibrate on the sequelae of acute experimental focal cerebral ischaemia.
Topics: Acute Disease; Animals; Bezafibrate; Brain Ischemia; Disease Models, Animal; Gerbillinae; Hemoglobins; Lactates; Male; Oxygen; Rats; Rats, Inbred Strains | 1989 |